Global Medical Radioisotopes Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028357 No. of Pages: 99 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Medical Radioisotopes market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Medical Radioisotopes market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Medical Radioisotopes in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Market Snapshot, By Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Main Market Players Analyzed in this report, including:
Rosatom
Polatom
NTP Radioisotopes
NRG
Nordion
IRE
Eckert & Ziegler Strahlen
China National Nuclear Corporation
ANSTO
The study objectives of this report are:
To study and analyze the global Medical Radioisotopes market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Medical Radioisotopes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Medical Radioisotopes manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Radioisotopes market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Medical Radioisotopes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Medical Radioisotopes are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Medical Radioisotopes Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Medical Radioisotopes Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Medical Radioisotopes
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Nuclear Therapy
3.2.2 Major Buyers in Equipment Radioactive Source
4 Market Segment: by Type
4.1 Medical Radioisotopes Type Introduction
4.1.1 Tc-99m
4.1.2 Cobalt-60
4.1.3 Iodine Radioisotopes
4.2 Global Medical Radioisotopes Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Medical Radioisotopes Type Introduction
5.1.1 Nuclear Therapy
5.1.2 Equipment Radioactive Source
5.1.3 Diagnosis
5.1.3 Others
5.2 Global Medical Radioisotopes Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Medical Radioisotopes Market by Region
6.2 North America Medical Radioisotopes Market 2016-2021
6.3 Europe Medical Radioisotopes Market 2016-2021
6.4 Asia Pacific Medical Radioisotopes Market 2016-2021
6.5 South America Medical Radioisotopes Market 2016-2021
6.6 Middle East and Africa Medical Radioisotopes Market 2016-2021
7 North America
7.1 North America Medical Radioisotopes Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Medical Radioisotopes Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Medical Radioisotopes Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Medical Radioisotopes Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Medical Radioisotopes Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Rosatom
12.1.1 Rosatom
Company Information
12.1.2 Rosatom
Medical Radioisotopes Product Portfolio, Specification and Application
12.1.3 Rosatom
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.1.4 Rosatom
Key Development
12.2 Polatom
12.2.1 Polatom
Company Information
12.2.2 Polatom
Medical Radioisotopes Product Portfolio, Specification and Application
12.2.3 Polatom
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.2.4 Polatom
Key Development
12.3 NTP Radioisotopes
12.3.1 NTP Radioisotopes
Company Information
12.3.2 NTP Radioisotopes
Medical Radioisotopes Product Portfolio, Specification and Application
12.3.3 NTP Radioisotopes
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.3.4 NTP Radioisotopes
Key Development
12.4 NRG
12.4.1 NRG
Company Information
12.4.2 NRG
Medical Radioisotopes Product Portfolio, Specification and Application
12.4.3 NRG
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.4.4 NRG
Key Development
12.5 Nordion
12.5.1 Nordion
Company Information
12.5.2 Nordion
Medical Radioisotopes Product Portfolio, Specification and Application
12.5.3 Nordion
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.5.4 Nordion
Key Development
12.6 IRE
12.6.1 IRE
Company Information
12.6.2 IRE
Medical Radioisotopes Product Portfolio, Specification and Application
12.6.3 IRE
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.6.4 IRE
Key Development
12.7 Eckert & Ziegler Strahlen
12.7.1 Eckert & Ziegler Strahlen
Company Information
12.7.2 Eckert & Ziegler Strahlen
Medical Radioisotopes Product Portfolio, Specification and Application
12.7.3 Eckert & Ziegler Strahlen
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.7.4 IRE
Key Development
12.9 ANSTO
12.9.1 ANSTO
Company Information
12.9.2 ANSTO
Medical Radioisotopes Product Portfolio, Specification and Application
12.9.3 ANSTO
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.9.4 ANSTO
Key Development
12.8.1 China National Nuclear Corporation
Company Information
12.8.2 China National Nuclear Corporation
Medical Radioisotopes Product Portfolio, Specification and Application
12.8.3 China National Nuclear Corporation
Medical Radioisotopes Revenue and Gross Margin (2019-2021)
12.8.4 China National Nuclear Corporation
Key Development
13 Global Medical Radioisotopes Market Forecast by Region by Type and by Application
13.1 Global Medical Radioisotopes Revenue Forecast 2022-2027
13.2 Global Medical Radioisotopes Forecast by Regions
13.3 Global Medical Radioisotopes Forecast by Type
13.4 Global Medical Radioisotopes Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com